Antiviral Drugs - Kuwait

Kuwait

The Antiviral Drugs market in Kuwait is expected to witness a substantial growth in the coming years.
By 2024, the projected revenue for this market is estimated to reach US$35.15m.
Furthermore, it is anticipated that the revenue will experience a steady annual growth rate of 1.91% from 2024 to 2029, resulting in a market volume of US$38.63m by the end of 2029.
When comparing the global scenario, it is noteworthy that United States will generate the highest revenue in this market.
In 2024 alone, the projected revenue for Antiviral Drugs market United States is expected to reach a staggering US$30,640.00m.
Kuwait's demand for antiviral drugs has surged due to the country's high prevalence of respiratory infections and the need to combat viral outbreaks effectively.

Key regions: Brazil, India, Australia, United States, United Kingdom

Market

Region

Region comparison

Currency

Analyst Opinion

The demand for Antiviral Drugs in Kuwait has been on the rise in recent years.

Customer preferences: Antiviral drugs are used to treat viral infections such as HIV, hepatitis B and C, influenza, and herpes. The increasing prevalence of these diseases has led to a rise in demand for antiviral drugs in Kuwait. In addition, the COVID-19 pandemic has further increased the demand for antiviral drugs as a potential treatment option.

Trends in the market: The antiviral drugs market in Kuwait has been experiencing significant growth in recent years. This growth can be attributed to the increasing prevalence of viral infections in the country. Additionally, the government has been investing in healthcare infrastructure and facilities, which has led to an increase in the availability of antiviral drugs. The market is also witnessing the entry of new players, which is further driving competition and innovation in the market.

Local special circumstances: Kuwait has a high prevalence of viral infections, which has led to an increase in demand for antiviral drugs. The country has a high incidence of hepatitis B and C, which are leading causes of liver cancer. In addition, the country has been affected by the COVID-19 pandemic, which has further increased the demand for antiviral drugs.

Underlying macroeconomic factors: Kuwait has a strong economy and a high standard of living. The government has been investing heavily in healthcare infrastructure and facilities, which has led to an increase in the availability of antiviral drugs. Additionally, the country has a well-developed healthcare system, which is able to provide high-quality healthcare services to its citizens. These factors have contributed to the growth of the antiviral drugs market in Kuwait.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.